It’s good news and bad news in a way. It casts a lot of doubt on the efficacy of beta-amyloid (plaque) targeting drugs that are in the pipeline right now.
It’s good news and bad news in a way. It casts a lot of doubt on the efficacy of beta-amyloid (plaque) targeting drugs that are in the pipeline right now.